Published Technical Guidance

1. World Health Organization. Regional Office for the Western Pacific. (2020). “Exploration of COVID-19 health-care worker cases: implications for action;” 21 August 2020. https://iris.wpro.who.int/handle/10665.1/14573.
2. World Health Organization. Regional Office for the Western Pacific. (2020). “Establishing integrated nationwide contact tracing systems;” 10 July 2020. https://iris.wpro.who.int/handle/10665.1/14553.
3. World Health Organization. Regional Office for the Western Pacific. (‎2020)‎. Epidemic analysis for response decision-making: systematic organization of multi-source information to inform response decisions. Manila: WHO Regional Office for the Western Pacific. https://apps.who.int/iris/handle/10665/333046.
4. World Health Organization. Regional Office for the Western Pacific. (2020). “Calibrating long-term non-pharmaceutical interventions for COVID-19: principles and facilitation tools;” 15 May 2020. https://iris.wpro.who.int/handle/10665.1/14520.
5. World Health Organization. Regional Office for the Western Pacific. (2020). “Holistic response strategies for COVID-19: Interim Guidance: Testing, surveillance and contact tracing;” 21 Apr 2020. https://iris.wpro.who.int/handle/10665.1/14512.
6. World Health Organization. Regional Office for the Western Pacific. (2020). “WHO Western Pacific regional action plan for the response to large-scale community outbreaks of COVID-19;” https://iris.wpro.who.int/handle/10665.1/14506.
7. World Health Organization. Regional Office for the Western Pacific. (2020). “Preparing for large-scale community transmission of COVID-19: Guidance for countries and areas in the WHO Western Pacific Region;” 28 Feb 2020. https://iris.wpro.who.int/handle/10665.1/14493

Scientific Publications

1. National Institute for Infectious Diseases (2020). Epidemiology of COVID-19 Outbreak on Cruise Ship Quarantined at Yokohama, Japan, February 2020. Emerging Infectious Diseases, 26(11), 2591-2597. https://dx.doi.org/10.3201/eid2611.201165.
2. Koh WC, Naing L, Chaw L, Rosledzana MA, Alikhan MF… Griffith M, Pastore R, Wong J. “What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors.” PLoS One. 2020 Oct 8;15(10): e0240205. doi: 10.1371/journal.pone.0240205. PMID: 33031427; PMCID: PMC7544065.
3. Yamagishi T, Ohnishi M, Matsunaga N, Kakimoto K, Kamiya H, Okamoto K… Griffith MM et al. “Environmental sampling for severe acute respiratory syndrome coronavirus 2 during a COVID-19 outbreak in the Diamond Princess cruise ship.” J Infect Dis; https://doi.org/10.1093/infdis/jiaa437.
4. Kato H, Kamiya H, Mori Y, Yahata Y, Morino S, Griffith M…. “Rubella outbreak among workers in three small- and medium-size business establishments associated with imported genotype 1E rubella virus-Shizuoka, Japan, 2015.” Vaccine. 2020 Oct 27;38(46):7278-7283. doi: 10.1016/j.vaccine.2020.09.045. Epub 2020 Oct 2. PMID: 33012606.
5. Wong J, Abdul Aziz ABZ, Chaw L, Mahamud A, Griffith MM, Lo YR, Naing L (2020). “High proportion of asymptomatic and presymptomatic COVID-19 infections in travelers and returning residents to Brunei.” Journal of Travel Medicine; https://doi.org/10.1093/jtm/taaa066.
6. Griffith MM, Yahata Y, Irie F, Kamiya H, Watanabe A, Kobayashi Y, et al. (2018). “Evaluation of an ad hoc paper-based syndromic surveillance system in Ibaraki evacuation centres following the 2011 Great East Japan Earthquake and Tsunami.” WPSAR; 9(4) doi: 10.5365/wpsar. 2017.8.3.006.
7. Griffith MM, Ochipurev A, Yamagishi T, Nishiki S, Jantsansengee B, Matsui T, et al. (2018). “An approach to building Field Epidemiology Training Program (FETP) trainees’ capacities as educators.” WPSAR; 9(3): doi: 10.5365/wpsar.2018.9.1.010.
8. Griffith MM, Fukusumi M, Kobayashi Y, Matsui Y, Nishiki S, Shimbashi R, et al. (2018). “Epidemiology of vaccine-preventable diseases in Japan: considerations for pre-travel advice for the 2019 Rugby World Cup and 2020 Summer Olympic and Paralympic Games.” WPSAR; 9(2): doi: 10.5365/2 wpsar.2017.8.4.002.
9. Terranella A, Rea V, Griffith M, Manning S, Sears S, Farmer A, et al. (2016). “Vaccine effectiveness of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine during a pertussis outbreak in Maine.” Vaccine; Mar 30; doi: 10.1016/j.vaccine.2016.03.083.
10. Bottero D, Griffith MM, Lara C, Flores D, Pianciola L, Galliard ME et al. (2013). “Bordetella holmesii in children suspected of pertussis in Argentina.” Epidemiol Infect.; 141(4):714-7.
11. Chin HB, Sipe TA, Elder R, Mercer SL, Chattopadhyay SK, Jacob V, Wethington HR, Kirby D, Elliston DB, Griffith M et al. (2012). “The effectiveness of group-based comprehensive risk-reduction and abstinence education interventions to prevent or reduce the risk of adolescent pregnancy, human immunodeficiency virus, and sexually transmitted infections: two systematic reviews for the Guide to Community Preventive Services.” Am J Prev Med.;42(3):282-94.
12. Mandal S, Tatti KM, Woods-Stout D, Cassiday PK, Faulkner AE Griffith MM et al. (2012). “Pertussis pseudo-outbreak linked to specimens contaminated by Bordetella pertussis DNA from clinic surfaces.” Pediatrics;129(2): e424-30.
13. Soler RE, Leeks KD, Razi S, Hopkins DP, Griffith M, Aten A et al. (2010). “A systematic review of selected interventions for worksite health promotion. The assessment of health risks with feedback.” Am J Prev Med;38(2 Suppl): S237-62.
14. Griffith M, Tajik M, Wing S. “Patterns of agricultural pesticide use in relation to socioeconomic characteristics of the population in the rural U.S. South.” Int J Health Serv.37(2):259-77.
15. DeLeeuw K, Fesperman C, Garrettson M, Griffith M, Hart H, Krier A. (2004). “Spanish‐speaking community of Asheboro Randolph County, North Carolina: An Action‐Oriented Community Diagnosis‐findings and recommendations for future action.” [On‐line] Available: http://www.hsl.unc.edu/PHpapers/Asheboro.pdf.